Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 10/30/2025 5:19:16 PM
Board Marks: 394
Posts Today: 0
Board Views Today: 1780
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
WUM
07/25/2025 12:07:29 PM
From another Board (stocktwits): A
(5)
ohm20
07/25/2025 12:01:08 AM
anybody seen this? - mRNA vaccine
(30)
JmcII
07/24/2025 11:58:22 PM
Yea but we cant get out of the
(3)
SporadicE
07/24/2025 11:47:26 PM
It is a new vaccine. It'll never get
(9)
JmcII
07/24/2025 11:38:58 PM
Sultans of Swing. Competition in other
(2)
Swinglikeseve
07/24/2025 11:21:17 PM
Footsteps !! We need to get to the goal
(4)
seemingly-harmless
07/24/2025 9:26:59 PM
anybody seen this? - mRNA vaccine
(8)
cardamine
07/24/2025 9:13:27 PM
AH, ok -- "we" with no antecedent,
(1)
Figgs
07/24/2025 8:03:37 PM
I never said shareholders should
(4)
twinter11
07/24/2025 8:00:33 PM
"No More shareholders communicating
(3)
cardamine
07/24/2025 7:12:11 PM
YES to Sean - No More shareholders
(19)
sean007
07/24/2025 5:49:39 PM
We hired our players to play...let them
(9)
Figgs
07/24/2025 4:31:21 PM
So RFK Jr seems totally obsessed with
(2)
sunray3
07/24/2025 1:58:43 PM
Well said. Free
(2)
Buddyboy20
07/24/2025 10:47:19 AM
Apparently, Colorectal Cancer (CRC)
(19)
PennySlayer
07/24/2025 10:34:58 AM
They also have not signed an office
(1)
hoops
07/24/2025 10:11:22 AM
Sorry. Must be a glitch on Schwab.
(1)
hoops
07/24/2025 9:34:26 AM
The manipulation gets ridiculous. 18K
(1)
Hyperbolic
07/24/2025 9:08:36 AM
Would you care to
(2)
pnwtri
07/24/2025 8:22:16 AM
Pestell is going to bring this thing
(4)
HHIGambler
07/24/2025 6:05:46 AM
I sent the link to the admin and
(2)
ohm20
07/24/2025 4:06:45 AM
What does this mean? That he needs a
(5)
skezan
07/23/2025 11:31:55 PM
CNPV fun facts: FAQs: Commissioners
(8)
HouseofCards
07/23/2025 9:39:53 PM
We can still sell like 250M shares if
(2)
mfglola
07/23/2025 9:11:09 PM
So FDA is now accepting applications
(8)
biloxiblues
07/23/2025 8:29:23 PM
We will be fine!
(2)
sean007
07/23/2025 8:01:14 PM
Money is never out of
(4)
Mr3Putt
07/23/2025 6:35:43 PM
Thoughts? Upwithstock IIRC has
(5)
bucweey34
07/23/2025 6:08:28 PM
Question for those with more knowledge
(1)
Buddyboy20
07/23/2025 5:50:30 PM
"I still vividly remember the sharp
(8)
sean007
07/23/2025 5:43:23 PM
"Beneath the surface"...remains the
(1)
KenChowder
07/23/2025 5:29:34 PM
Sherlock, companies who make tender
(6)
sjacobs26
07/23/2025 4:41:02 PM
I could be off here, but considering
(10)
sherlock57
07/23/2025 3:57:35 PM
Sunray--Imagine the response of the
(18)
cardamine
07/23/2025 3:07:08 PM
Wiki even makes a separate section for
(2)
cardamine
07/23/2025 2:53:12 PM
yeah there's been the proverbial "blood
(1)
sunray3
07/23/2025 1:12:31 PM
Oh, I'm sure as I suspect you are that
(7)
twinter11
07/23/2025 12:57:30 PM
"I don't pretend to know the motives
(7)
sunray3
07/23/2025 12:07:51 PM
Now mind you, I don't pretend to know
(3)
sunray3
07/23/2025 11:11:08 AM
Definitely BS, you're right...the MM
(7)
Tprovo
07/23/2025 10:43:31 AM
Gap filled at .28 this AM and so did my
(2)
Evil Rabbit
07/23/2025 10:03:41 AM
That premarket action was some BS. 11k
(6)
dfwl28
07/23/2025 9:55:10 AM
Side effects of Ipilimumab, also known
(4)
ohm20
07/23/2025 4:01:10 AM
Ipilimumab Safety Profile: Associated
(16)
ohm20
07/23/2025 3:50:15 AM
Based on above hypothesis, It could
(11)
KenChowder
07/23/2025 3:13:18 AM
MGK wrote: Based on above hypothesis,
(11)
ohm20
07/23/2025 2:56:21 AM
Sorry Ohm, I'm not smart enough to
(13)
USS JOHNSTON
07/22/2025 11:27:56 PM
I am also not a doctor, biloxi, so I
(5)
MGK_2
07/22/2025 8:09:36 PM
I wrote
(4)
biloxiblues
07/22/2025 7:37:02 PM
I am not a Doctor, but this is
(4)
Newer
Older
Recent Articles
Bioretec Ltd Adjusts H1 Report: Financial Highlights and Outlook
Tetragon Financial Group Reveals September 2025 Insights
Bioretec Ltd Updates Financial Report Details for 2025
Loomis Reports Robust Performance in Q3 2025 with Growth
Investments from Optiver and Qube Strengthen McKay Brothers
Strategic Investments by Optiver and QRT Propel McKay Brothers
Mycenax Partners with RIN Institute to Transform ADC Technology
Transforming Enterprises: FastGPT's No-code AI Solutions for 2025
Corbus Pharmaceuticals Moves Forward with Public Offering
S&P 500 Achieves Historic Winning Streak and Market Insights
Key Challenges Highlighted by Michael Saylor for Growth Strategy
Ecer.com Launches Innovative AI Marketplace Strategy for Trade
Bioretec Ltd Revises 2025 Half-Year Report with Key Updates
DigitalXForce Achieves Prestigious Leader Status in IDC Assessment
Danske Bank Sees Positive Trends and Growth for 2025
Sampo plc's Latest Share Buyback Program and Results
Exciting Developments in Kudu Well Appraisal by BW Energy
Aalberts N.V. Strengthens Position with GVT Acquisition
Nxera Pharma's Innovations and Financial Report for 2025
Nxera Pharma Expands Manufacturing to Meet Growing Demand for QUVIVIQ®
Vistin Pharma Reports Strong Q3 Results and Market Growth
Corbus Pharmaceuticals Sets Price for New Stock Offering
Introducing a New Executive Team Member at Realkredit Danmark
Aalberts Enhances Market Position Through Latest Acquisition
Exploring the Future of Green Hydrogen Development
Aker Solutions ASA Sees Revenue Boost in Third Quarter
Aker Solutions Reports Strong Performance in Q3 2025
Aker Solutions’ Record Growth and Promising Future Outlook
Investigation Launched into Conduent's Major Data Breach Event
Vallourec Secures Groundbreaking Contract for Deepwater Project
Essential Patient Inquiries for Portable X-Ray Scheduling
Exploring Affordable Coastal Living Alternatives Near Beaches
Intensity Therapeutics Sees Dip After Surging to New Heights
Marimekko's Strategic Growth and Operations in 2025
SCOR Reports Impressive Q3 2025 Earnings and Growth Metrics
SPIE Reports Robust Growth and Strategic Acquisitions in 2025
Trifork Group Achieves 4.7% Revenue Growth in Q3 Growth Report
Ekspress Grupp’s Revenue Growth and Future Strategies Unveiled
Marimekko Sees Growth in Q3 Revenue and Profits for 2025
Syensqo's Strategic Shift: Selling Oil & Gas Division to SNF
Elis Expands its Reach in Germany with New Acquisition Deal
Biotalys' EVOCA Biofungicide Nears EPA Approval, Changing Crop Protection
Hyundai and NVIDIA Unite for Advanced AI Innovation
Transforming Manufacturing: NVIDIA and SK Group's AI Collaboration
NVIDIA and Samsung Launch Revolutionary AI Manufacturing Factory
NVIDIA and South Korea Join Forces to Revolutionize AI Landscape
Vallourec Secures Major Offshore Contract with TechnipFMC
SCOR Achieves Remarkable Q3 2025 with Strong Net Income
Realsee Partners with Linkhome to Transform Real Estate with AI
Revolutionizing Retirement: How Physicians Are Investing Wisely